期刊文献+

乳腺癌细胞中miR-1246、ZO-1、vimentin的表达及相关性研究 被引量:3

Expression and correlation of miR-1246,ZO-1 and vimentin in breast cancer cells
原文传递
导出
摘要 目的检测miR-1246、ZO-1、vimentin在乳腺正常上皮细胞MCF10A和乳腺癌癌细胞MCF7、MDA-MB-231中的表达,并探讨miR-1246在促进乳腺癌上皮-间质化(epithelial-mesenchymal transition,EMT)中的作用。方法用荧光定量PCR法检测乳腺正常上皮细胞MCF10A、乳腺癌细胞MCF7、MDA-MB-231中miR-1246的相对表达量,用免疫印迹法检测乳腺正常上皮细胞MCF10A、乳腺癌细胞MCF7、MDA-MB-231中紧密连接蛋白ZO-1、波形蛋白vimentin的表达情况。采用SPSS 16.0统计软件分析,用U检验、t检验和Spearman相关分析分析数据。结果miR-1246和ZO-1在恶性乳腺癌细胞中的表达明显降低(P<0.05),vimentin在恶性乳腺癌细胞中的表达明显增加(P<0.05),miR-1246与ZO-1表达呈正相关(r=0.940,P<0.05),miR-1246与vimentin表达呈负相关(r=-0.714,P<0.05)。结论 miR-1246表达水平与EMT标志物ZO-1、vimentin的表达水平存在一定的相关性,提示miR-1246在促进乳腺癌EMT过程中扮演重要角色。 Objective To investigate the expression and correlation of ZO-1,vimentin and miR-1246 in normal breast epithelial cells( MCF10A) and breast cancer cells( MCF7,MDA-MB-231),and analyze the role of miR-1246 in promoting breast cancer epithelial-mesenchymal transition( EMT). Methods The relative expression levels of miR-1246 in MCF10 A,MCF7 and MDA-MB-231 were detected by q PCR assay; the expression of ZO-1 and vimentin protein in MCF10 A,MCF7 and MDA-MB-231 were detected by WB assay. Data were analyzed using U test,t test and spearman rank correlation analysis by SPSS 16. 0. Results The expression of miR-1246 and ZO-1 in malignant breast cancer cells were significantly decreased( P〈0. 05),the expression of vimentin in malignant breast cancer cells was significantly increased( P〈0. 05). MiR-1246 was positively correlated with ZO-1 expression( r = 0. 940,P〈0. 05),miR-1246 and vimentin expression were negatively correlated( r =- 0. 714,P〈0. 05). Conclusion The expression level of miR-1246 and EMT markers is correlated,so miR-1246 is suggested to play an important role in the promotion of EMT in breast cancer.
出处 《中华全科医学》 2016年第8期1373-1375,共3页 Chinese Journal of General Practice
基金 浙江省科技计划项目(2012C37037) 浙江省台州市科技计划项目(2011ky0701) 浙江省台州市医学会科研研究项目(TZSYXH15-27)
关键词 miR-1246 ZO-1 VIMENTIN 乳腺肿瘤 Mir-1246 ZO-1 Vimentin Breast cancer
  • 相关文献

参考文献15

  • 1Siege 1R, Naishadham D, Jemal A. Cancer statistics, 2013 [ J]. CA Cancer Journal for Clinicians,2013,63 ( 1 ) :11-30.
  • 2Enserink M. A push to fight cancer in the developing world [ J ]. Sci- ence,2011,331 (6024) :1548-1550.
  • 3郑刚,杨靖,左文述,于志勇,刘岩松,郑美珠,王圣芳.中国乳腺癌前哨淋巴结活检验证阶段研究结果的系统评价[J].中华医学杂志,2011,91(6):361-365. 被引量:36
  • 4Zhang Y, Liao JM, Zeng SX, et al. p53 downregnlates Down syndrome- associated DYRK1A through miR-1246 [ J ]. EMBO Reports, 2011,12 (8) :811-$17.
  • 5Liao JM,Zhou X,Zhang Y, et al. MiR-12g6: a new link of the p53 family with cancer and Down syndrome [ J ]. Cell Cycle, 2012, 11 (lg) :2624-2630.
  • 6Wang Q,Li D,Li Z,et al. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen[J]. Oncogene,2011,30(36) :3875-3886.
  • 7Fanning AS , Van Itallie CM, Anderson JM. Zonula occludens-1 and-2 regulate apical cell structure and the zonula adherens cytoskeleton in polarized epithelia[ J]. Mol Biol Cell,2012,23 (4) :577-590.
  • 8王晔恺,周吉航,曾芳,黄燕燕,周世权,刘晓光.非小细胞肺癌组织中ZO-1的表达及其临床意义[J].中国肺癌杂志,2011,14(2):146-150. 被引量:5
  • 9Ni SH, Xu LQ, Huang JF, et al. Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer [ J ]. Int J Clin Exp Patho1,2013,6 ( 12 ) :2887-2895.
  • 10郭兴军,王敏,江建新,石程剑,胡均,黄焕军.ZO-1和Claudin-1在胆管癌中的表达及其意义[J].中华实验外科杂志,2014,31(8):1739-1741. 被引量:4

二级参考文献69

  • 1黄志强.肝门部胆管癌外科治疗面临的问题与出路[J].中华实验外科杂志,2004,21(7):773-775. 被引量:78
  • 2徐晓明,赵祥生,周建农,唐金海,陈环球,张彤,周大庆,莫伏根,秦建伟,姜爱仁.前哨淋巴结检测在乳腺癌治疗中的意义[J].中华普通外科杂志,2004,19(8):494-495. 被引量:12
  • 3江泽飞,姚开泰,宋三泰.乳腺癌治疗的新循证医学证据和临床实践[J].中华医学杂志,2005,85(43):3025-3027. 被引量:29
  • 4Kra DN,Weaver DL,Alex JC,et al.Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol,1993,2:335-340.
  • 5Giuliano AE,Kirgan DM,Guenther M,et al.Lymphatic mapping and sentinel lymphadenectomy for breast cancer.J Ann Surg,1994,220:391-401.
  • 6Giuliano AE.Mapping a pathway for axillary staging:a personal perspective on the current status of sentinel lymph node dissection for breast cancer.Arch Surg,1999,134:195.
  • 7Choi SH,Barsky SH,Chang HR.Clinicopathologic ananlysis of sentinel lymph node mapping in early breast cancer.Breast J,2003,9:153.
  • 8Cody HS 3rd,Fey J,Akhurst T,et al.Complementarity of blue dye and isotope in sentinel node localization for breast cancer:univariate and multivarirate analysis of 966 procedures.Ann Surg Oncol,2001,8:13-19.
  • 9Giuliano AE,Kirgan DM,Guenther JM,et al.Lymphatic mapping and sentinel lymphadectomy for breast cancer.Ann Surg,1994,220:391-401.
  • 10Krag D,Weaver D,Ashikaga T,et al.The sentinel node in breast cancer-a multicenter validation study.J N Engl J Med,1998,339:941-946.

共引文献50

同被引文献9

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部